Cargando…
Retrospective analysis of leflunomide and low-dose methylprednisolone for the treatment of diabetic nephropathy combined with membranous nephropathy
Diabetic kidney disease (DKD) combined with Membranous Nephropathy (MN) was observed in some patients with the increasing of Diabetic patients. However, no treatment guidelines are available for DKD combined with MN. In this study, we for the first time analyzed the safety and efficacy of leflunomid...
Autores principales: | Shang, Shunlai, Cui, Shaoyuan, Wang, Wenjuan, Wang, Chao, Li, Ping, Li, Wenge, Li, Qinggang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468778/ https://www.ncbi.nlm.nih.gov/pubmed/36111292 http://dx.doi.org/10.3389/fendo.2022.941215 |
Ejemplares similares
-
Efficacy of leflunomide combined with prednisone for the treatment of PLA2R-associated primary membranous nephropathy
por: Guo, Yaling, et al.
Publicado: (2020) -
Clinical efficacy and safety of full-dose versus half-dose corticosteroids plus leflunomide for IgA nephropathy
por: Li, Yebei, et al.
Publicado: (2021) -
Comparison of combined leflunomide and low-dose corticosteroid therapy with full-dose corticosteroid monotherapy for progressive IgA nephropathy
por: Min, Lulin, et al.
Publicado: (2017) -
Efficacy of Leflunomide, Telmisartan, and Clopidogrel for Immunoglobulin A Nephropathy: A Randomized Controlled Trial
por: Wu, Jie, et al.
Publicado: (2016) -
Clinicopathological features and prognosis of idiopathic membranous nephropathy with thyroid dysfunction
por: Wang, Peiheng, et al.
Publicado: (2023)